Two nanobodies – fragments of antibodies – that target the highly conserved protein alpha-synuclein for degradation reduce neurotoxicity in a rat model of Parkinson’s Disease (PD).

Browse Articles

Nature events Directory

  • This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.

    Committee on Publication Ethics